{"id":7,"date":"2020-08-18T21:03:19","date_gmt":"2020-08-18T21:03:19","guid":{"rendered":"https:\/\/thenewdaystudy.com\/?page_id=7"},"modified":"2021-08-11T22:26:40","modified_gmt":"2021-08-11T22:26:40","slug":"for-healthcare-providers","status":"publish","type":"page","link":"https:\/\/thenewdaystudy.com\/for-healthcare-providers","title":{"rendered":"For Healthcare Providers"},"content":{"rendered":"<div id=\"cf-geoplugin-banner-387\" class=\"cf-geoplugin-banner cache post-387 type-cf-geoplugin-banner status-publish entry has-post-thumbnail cf-geoplugin-banner-387\" data-id=\"387\" data-nonce=\"3789084a223b004cdf476e0a83a002d89621a104b1054df7780173b97b149b9d\"><strong>You are accessing a US-based website.<\/strong>\r\n \r\n<em>The owner of the Website is based in the State of Georgia in the United States. We provide this Website for use only by persons located in the United States. We make no claims that the Website or any of its content is accessible or appropriate outside of the United States. Access to the Website may not be legal by certain persons or in certain countries. If you access the Website from outside the United States, you do so on your own initiative and are responsible for compliance with local laws.<\/em>\r\n \r\n<\/div>\n\n\n\n<h2 class=\"has-text-align-center is-style-default has-theme-primary-color has-text-color wp-block-heading\">What are the NEW DAY Study Objectives?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:25px\">The <strong>NEW DAY<\/strong> Study evaluates an FDA-approved long-acting steroid delivery system treatment option and an FDA-approved short-acting anti-VEGF treatment option. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:25px\"><\/p>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\"><strong>For More Information Visit:<\/strong><br><a rel=\"noreferrer noopener\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04469595?term=new+day&amp;draw=2&amp;rank=1\" target=\"_blank\">Clinicaltrials.gov<\/a>  or <\/h2>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-theme-primary-background-color has-text-color has-background\" href=\"mailto: newdayinfo@alimerasciences.com\" style=\"border-radius:8px;color:#f6f6f6\">Email Us<\/a><\/div>\n<\/div>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">The NEW DAY Study can also be found by searching NCT04469595 on clinicaltrials.gov<\/p>\n","protected":false},"excerpt":{"rendered":"<p>What are the NEW DAY Study Objectives? The NEW DAY Study evaluates an FDA-approved long-acting steroid delivery system treatment option and an FDA-approved short-acting anti-VEGF treatment option. For More Information Visit:Clinicaltrials.gov or The NEW DAY Study can also be found by searching NCT04469595 on clinicaltrials.gov<\/p>\n","protected":false},"author":1,"featured_media":215,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"class_list":["post-7","page","type-page","status-publish","has-post-thumbnail","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>For Healthcare Providers - New Day Study<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"For Healthcare Providers - New Day Study\" \/>\n<meta property=\"og:description\" content=\"What are the NEW DAY Study Objectives? The NEW DAY Study evaluates an FDA-approved long-acting steroid delivery system treatment option and an FDA-approved short-acting anti-VEGF treatment option. For More Information Visit:Clinicaltrials.gov or The NEW DAY Study can also be found by searching NCT04469595 on clinicaltrials.gov\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thenewdaystudy.com\/for-healthcare-providers\" \/>\n<meta property=\"og:site_name\" content=\"New Day Study\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-11T22:26:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"907\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers\",\"url\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers\",\"name\":\"For Healthcare Providers - New Day Study\",\"isPartOf\":{\"@id\":\"https:\/\/thenewdaystudy.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg\",\"datePublished\":\"2020-08-18T21:03:19+00:00\",\"dateModified\":\"2021-08-11T22:26:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thenewdaystudy.com\/for-healthcare-providers\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers#primaryimage\",\"url\":\"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg\",\"contentUrl\":\"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg\",\"width\":1500,\"height\":907},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thenewdaystudy.com\/for-healthcare-providers#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thenewdaystudy.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For Healthcare Providers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thenewdaystudy.com\/#website\",\"url\":\"https:\/\/thenewdaystudy.com\/\",\"name\":\"New Day Study\",\"description\":\"A NEW DAY in DME Treatment\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thenewdaystudy.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"For Healthcare Providers - New Day Study","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"For Healthcare Providers - New Day Study","og_description":"What are the NEW DAY Study Objectives? The NEW DAY Study evaluates an FDA-approved long-acting steroid delivery system treatment option and an FDA-approved short-acting anti-VEGF treatment option. For More Information Visit:Clinicaltrials.gov or The NEW DAY Study can also be found by searching NCT04469595 on clinicaltrials.gov","og_url":"https:\/\/thenewdaystudy.com\/for-healthcare-providers","og_site_name":"New Day Study","article_modified_time":"2021-08-11T22:26:40+00:00","og_image":[{"width":1500,"height":907,"url":"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thenewdaystudy.com\/for-healthcare-providers","url":"https:\/\/thenewdaystudy.com\/for-healthcare-providers","name":"For Healthcare Providers - New Day Study","isPartOf":{"@id":"https:\/\/thenewdaystudy.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thenewdaystudy.com\/for-healthcare-providers#primaryimage"},"image":{"@id":"https:\/\/thenewdaystudy.com\/for-healthcare-providers#primaryimage"},"thumbnailUrl":"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg","datePublished":"2020-08-18T21:03:19+00:00","dateModified":"2021-08-11T22:26:40+00:00","breadcrumb":{"@id":"https:\/\/thenewdaystudy.com\/for-healthcare-providers#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thenewdaystudy.com\/for-healthcare-providers"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thenewdaystudy.com\/for-healthcare-providers#primaryimage","url":"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg","contentUrl":"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final.jpg","width":1500,"height":907},{"@type":"BreadcrumbList","@id":"https:\/\/thenewdaystudy.com\/for-healthcare-providers#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thenewdaystudy.com\/"},{"@type":"ListItem","position":2,"name":"For Healthcare Providers"}]},{"@type":"WebSite","@id":"https:\/\/thenewdaystudy.com\/#website","url":"https:\/\/thenewdaystudy.com\/","name":"New Day Study","description":"A NEW DAY in DME Treatment","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thenewdaystudy.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"featured_image_src":"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final-600x400.jpg","featured_image_src_square":"https:\/\/thenewdaystudy.com\/wp-content\/uploads\/2021\/01\/healthcare-providers-final-600x600.jpg","_links":{"self":[{"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/pages\/7","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7"}],"version-history":[{"count":10,"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/pages\/7\/revisions"}],"predecessor-version":[{"id":391,"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/pages\/7\/revisions\/391"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=\/wp\/v2\/media\/215"}],"wp:attachment":[{"href":"https:\/\/thenewdaystudy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}